Skip to content

Clinical trials

Phase 3 COVID-19 trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 3 Country / region: United Kingdom Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
202026
202110
20226
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated7
Recruiting5
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)7
Gilead Sciences5
AstraZeneca4
University of Minnesota3
Cambridge University Hospitals NHS Foundation Trust2
Novartis Pharmaceuticals2
University of Oxford2
Alexion Pharmaceuticals, Inc.1
Ashford and St. Peter's Hospitals NHS Trust1
Atea Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1946
Coronavirus Infections14
Severe Acute Respiratory Syndrome8
Virus Diseases7
Coronaviridae Infections5
Nidovirales Infections5
RNA Virus Infections5
Pneumonia4
Community-Acquired Pneumonia2
Cytokine Release Syndrome2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.